NEUROLOGISK KLINIK ApS: Financial statements 2020
CVR: 31748429
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 160,599 and a net result of DKK 194,614 compared with DKK 144,705 the year before. That is a decrease of 38% compared with the year before. Equity in the 2020 report amounted to DKK 863,386. The solvency ratio was 84%.
- Gross Profit
- DKK 160,599
- Profit/Loss
- DKK 194,614
- Equity
- DKK 863,386
- Total Assets
- DKK 1,027,384
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 161K | 195K | 863K | - |
| 2019 | - | 259K | 145K | 521K | - |
| 2018 | - | 89K | 13K | 376K | 0 |
| 2017 | - | 202K | 100K | 363K | 0 |
| 2016 | - | 112K | 30K | 262K | - |
Official annual report
How creditworthy is NEUROLOGISK KLINIK ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NEUROLOGISK KLINIK ApS has published its annual report for 2019. Gross profit came to DKK 258,911, and the net result was DKK 144,705.
About NEUROLOGISK KLINIK ApS
NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.